Description

Fresenius Kabi's INFUFIL-AIR 0.2 µM Filter is an advanced in-line infusion filter engineered to enhance the safety of intravenous therapy. This specialized filter is designed to effectively prevent the administration of particles, air, micro-organisms, and endotoxins, thereby significantly reducing the risk of infection from contaminated infusion solutions.

Key Features

• Filtration Pore Size: The filter features a 0.2 µm pore size, providing robust filtration capabilities.
• Positively Charged Membrane: Its unique positively charged membrane enhances the retention of bacteria and negatively charged endotoxins, ensuring cleaner infusion solutions.
• Extended Use Duration: Suitable for use up to 96 hours, making it highly efficient for prolonged medical applications.

Design and Specifications

• Filter Surface Area: Available with an active filter surface area of 10 cm², with a variant reported at 5.7 cm².
• Filter Diameter: Measures 30 mm in diameter.
• Pressure Resistance: Capable of withstanding pressure up to 7 bar.
• Material: Constructed with a hydrophilic cellulose acetate membrane.

Safety and Compliance

• Sterility: Each filter is individually sterile packed.
• Material Safety: Free from latex, PVC, and DEHP.
• Certification: CE marked, ensuring compliance with European health, safety, and environmental protection standards.

Performance

The filter's positively charged membrane is particularly effective, retaining endotoxins with passage below 0.03 EU/ml for up to 96 hours. This feature makes it uniquely suitable for safe use beyond 24 hours of infusion, a characteristic not commonly found in other filters.

Packaging

The product is available as single units or in cartons containing 100 units, providing flexibility for various institutional needs. Additionally, the filter does not require refrigeration, simplifying storage requirements.

This comprehensive set of features makes the INFUFIL-AIR 0.2 µM Filter an essential component for healthcare providers seeking to maintain high standards of intravenous therapy safety. Its design and performance attributes align with the rigorous demands of medical environments, ensuring reliable and effective filtration over extended periods.